To determine whether receptor cleavage is involved in the production of cell-derived sTNFR1 and sTNFR2 by TNBC cells, we used the broad spectrum metalloproteinase inhibitor marimastat [85] and the ADAM17 inhibitor TAPI-0 [86] which did not affect tumor cell growth. This evidence concerns the gene ADAM17 and neoplasm.